Phase Genomics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1617 8th Ave N, Seattle, Washington, 981...Phone Number
(833) 742-7436Website
www.phasegenomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Phase Genomics
Phase Genomics applies proprietary proximity ligation technology to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. In addition to a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples, they also offer an industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company's mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.Explore more
Phase Genomics Org Chart
MV
Staff Engineering Lead
MM
Senior Research Scientist
MI
Research Scientist II
DG
Bioinformatic Scientist II
ER
Research Scientist II
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phase Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Phase Genomics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Phase Genomics had a recent Job posting/layoffs
Phase Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Phase Genomics has new funding data
Earning: See what the market has to say on Phase Genomics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Phase Genomics
Product Launch: Get notified when Phase Genomics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Phase Genomics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Phase Genomics
Find 3 more new buyers
Compare Similar Companies to Phase Genomics
Compare insights from companies similar to Phase Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phase Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phase Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phase Genomics.
Phase Genomics financials insights
Gather financial insights about Phase Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$213K
2022
Grant
$5.5M
2024
Other Financing Round
$1.5M
Phase Genomics Tech Stack
A closer look at the technologies used by Phase Genomics
Most Recent Scoops
Funding
Project
Award, Spending/Investment, Engineering, Analytics & Insights, Machine Learning, Bioengineering, Risk
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Funding
Phase Genomics News & Media
Phase Genomics gets $1.5M grant from Gates Foundation to fight cow burp methane
Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into two important areas: killing drug-resistant bacteria and battling methane-producing microorganisms that live in the guts of cows and other ruminants. The new grant will support a year-long project to create an antimicrobial discovery platform to tackle these challenges. The focus is on Campylobacter infections, which are among the most common human infections and can caPhase Genomics Announces Funding to Accelerate Discovery of New Lysin-Based Precision Antimicrobials
SEATTLE--(BUSINESS WIRE)--Phase Genomics, Inc., a leading innovator at the forefront of genomics technology development, today announced $1.5MM in new funding from the Bill & Melinda Gates Foundation to fuel a new antimicrobial discovery platform. Leveraging the power of lysins, phage-derived proteins that selectively kill specific bacteria and archaea, the program aims to address two immediate threats that will shape the next century: a growing global antibiotic resistance crisis and the cPhase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia
SEATTLE--(BUSINESS WIRE)-- #OncoTerra--Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation sequencing system. The platform offers a revolutionary leap toward rapid risk stratification for acute myeloid leukemia (AML). Traditional cytogenetics has relied on a battery of assays for comprehensive evaluation,Phase Genomics Named Metagenomics Innovation Of The Year for 2023 by BioTech Breakthrough Awards for “Transformative Innovations Advancing the Frontiers of Global Public Health”
SEATTLE--(BUSINESS WIRE)-- #genomics--Phase Genomics awarded Biotech Breakthrough's "Metagenomics Innovation Of The Year" for its breakthrough ProxiMeta™ metagenomics platform.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phase Genomics
Sign Up For FreeTo access detailed company insights
Phase Genomics applies proprietary proximity ligation technology to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. In addition to a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals,... Read More
